Cheviot Value Management, LLC Pfizer Inc Transaction History

Cheviot Value Management, LLC

$490 Million
Q3 2024

A detailed history of Cheviot Value Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cheviot Value Management, LLC holds 416,060 shares of PFE stock, worth $11 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares

416,060

Previous 427,539 2.68%

Holding current value

$11 Million

Previous $12 Million 0.65%

% of portfolio

2.46%

Previous 2.52%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $317,968 - $360,325	-11,479 Reduced 2.68%	416,060 $12 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $558,549 - $654,515	22,112 Added 5.45%	427,539 $12 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $2.07 Million - $2.37 Million	79,833 Added 24.52%	405,427 $11.3 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $518,497 - $673,471	19,843 Added 6.49%	325,594 $9.37 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $335,404 - $392,054	10,452 Added 3.54%	305,751 $10.1 Million
Q2 2023 Nov 07, 2023	BUY	$36.12 - $41.79 $883,495 - $1.02 Million	24,460 Added 9.03%	295,299 $10.8 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $210,539 - $274,091	5,345 Added 2.01%	270,839 $11.1 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $105,627 - $137,885	-2,530 Reduced 0.94%	265,494 $13.6 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $76,711 - $93,645	1,753 Added 0.66%	268,024 $11.7 Million
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $127,399 - $151,055	-2,738 Reduced 1.02%	266,271 $14 Million
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $792,893 - $982,494	17,331 Added 6.89%	269,009 $13.9 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $78,094 - $115,762	-1,890 Reduced 0.75%	251,678 $14.9 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $175,800 - $225,831	4,479 Added 1.8%	253,568 $10.9 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $215,747 - $244,405	6,008 Added 2.47%	249,089 $9.75 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $818,596 - $923,212	24,443 Added 11.18%	243,081 $8.81 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $186,929 - $237,697	5,585 Added 2.62%	218,638 $8.05 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $195,580 - $229,460	6,160 Added 2.98%	213,053 $7.82 Million
Q2 2020 Aug 17, 2020	BUY	$30.12 - $36.54 $222,165 - $269,519	7,376 Added 3.7%	206,893 $6.77 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $96,767 - $138,259	-3,580 Reduced 1.76%	199,517 $6.51 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $12,542 - $14,234	381 Added 0.19%	203,097 $7.96 Million
Q3 2019 Nov 15, 2019	BUY	$32.49 - $42.13 $13,320 - $17,273	410 Added 0.2%	202,716 $7.28 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $306,157 - $343,744	-8,279 Reduced 3.93%	202,306 $8.76 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $55,950 - $61,470	-1,492 Reduced 0.7%	210,585 $8.94 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $329,764 - $375,967	-8,572 Reduced 3.88%	212,077 $9.26 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $220,573 - $267,542	-6,399 Reduced 2.82%	220,649 $9.72 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $211,698 - $225,692	-6,419 Reduced 2.75%	227,048 $8.24 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $66,500 - $77,149	2,084 Added 0.9%	233,467 $8.29 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $30,732 - $32,607	924 Added 0.4%	231,383 $8.38 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $159,557 - $175,770	5,147 Added 2.28%	230,459 $8.23 Million
Q2 2017 Aug 11, 2017	BUY	N/A	225,312	225,312 $7.57 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheviot Value Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cheviot Value Management, LLC with notifications on news.

Account

Cheviot Value Management, LLC Pfizer Inc Transaction History